Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1996; 27:67-75
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, J.
Right arrow Articles by Woosley, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, J.
Right arrow Articles by Woosley, R.

Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group

JH Levine, A Massumi, MM Scheinman, RA Winkle, EV Platia, DA Chilson, A Gomes, and RL Woosley

Arrhythmia Service, St. Francis Hospital, Roslyn, New York 11576, USA.

OBJECTIVES. We sought to determine the response rate and safety of intravenous amiodarone in patients with ventricular tachyarrhythmias refractory to standard therapies. BACKGROUND. Numerous small retrospective reports suggest a response of refractory ventricular tachyarrhythmias to intravenous amiodarone, yet no controlled prospective trials exist. METHODS. Two hundred seventy-three patients with recurrent hypotensive ventricular tachyarrhythmias refractory to lidocaine, procainamide and bretylium were randomized to receive one of three doses of intravenous amiodarone: 525, 1,050 or 2,100 mg/24 h (mean [+/- SE] dose 743.7 +/- 418.7, 1,175.2 +/- 483.7, 1,921.2 +/- 688.8 mg, respectively) by continuous infusion over 24 h. RESULTS. Of the 273 patients, 110 (40.3% response rate) survived 24 h without another hypotensive ventricular tachyarrhythmic event while being treated with intravenous amiodarone as a single agent (primary end point). A significant difference in the time to first recurrence of ventricular tachyarrhythmia (post hoc analysis) over the first 12 h was observed when the combined 1,050- and 2,100-mg dose groups were compared with the 525-mg dose group (p = 0.046). The number of supplemental (150 mg) infusions of intravenous amiodarone (given for breakthrough destabilizing tachyarrhythmias) during hours 0 to 6 (prespecified secondary end point) was significantly greater in the 525-mg dose group than in the 2,100-mg dose group (1.09 +/- 1.57 vs. 0.51 +/- 0.97, p = 0.0043). However, there was no clear dose-response relation observed in this trial with respect to success rates (primary end point), time to first recurrence of tachyarrhythmia (post hoc analysis) or mortality (secondary end point) over 24 h. CONCLUSIONS. Intravenous amiodarone is a relatively safe therapy for ventricular tachyarrhythmias refractory to other medications.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Dunning, A. Fabbri, P. H. Kolh, A. Levine, U. Lockowandt, J. Mackay, A. J. Pavie, T. Strang, M. I.M. Versteegh, S. A.M. Nashef, et al.
Guideline for resuscitation in cardiac arrest after cardiac surgery
Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 3 - 28.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
D. J. Cushing, M. P. Adams, W. D. Cooper, P. R. Kowey, and R. J. Lipicky
Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants
J. Clin. Pharmacol., April 1, 2009; 49(4): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
B. P.J. Leeuwenburgh, M. I.M. Versteegh, J. J. Maas, and J. Dunning
Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?
Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1148 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
D R Tomlinson, P Cherian, T R Betts, and Y Bashir
Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
Emerg. Med. J., January 1, 2008; 25(1): 15 - 18.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. H. Levy, K. A. Tanaka, and J. M. Bailey
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2008; 3(2008): 77 - 110.
[Full Text]


Home page
Card Surg AdultHome page
M. P. Anstadt and J. E. Lowe
Cardiopulmonary Resuscitation
Card. Surg. Adult, January 1, 2008; 3(2008): 487 - 506.
[Full Text]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
PediatricsHome page
The International Liaison Committee on Resuscitati
The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support
Pediatrics, May 1, 2006; 117(5): e955 - e977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 7.2: Management of Cardiac Arrest
Circulation, December 13, 2005; 112(24_suppl): IV-58 - IV-66.
[Full Text] [PDF]


Home page
CirculationHome page
Part 4: Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54.
[Full Text] [PDF]


Home page
CirculationHome page
Part 6: Pediatric Basic and Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
U. N. Srivatsa, R. Ebrahimi, A. El-Bialy, and R. Y. Wachsner
Electrical Storm: Case Series and Review of Management
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 237 - 246.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. T. Cheung, S. J. Weiss, J. S. Savino, W. J. Levy, J. G. Augoustides, A. Harrington, and T. J. Gardner
Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients
Ann. Thorac. Surg., August 1, 2003; 76(2): 535 - 541.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. M. Bailey, K. A. Tanaka, and J. H. Levy
Cardiac Surgical Pharmacology
Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118.
[Full Text]


Home page
Card Surg AdultHome page
M. P. Anstadt and J. E. Lowe
Cardiopulmonary Resuscitation
Card. Surg. Adult, January 1, 2003; 2(2003): 471 - 494.
[Full Text]


Home page
ANN INTERN MEDHome page
R. S. Wright, G. S. Reeder, C. A. Herzog, R. C. Albright, B. A. Williams, D. L. Dvorak, W. L. Miller, J. G. Murphy, S. L. Kopecky, and A. S. Jaffe
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
Ann Intern Med, October 1, 2002; 137(7): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Callans
Management of the Patient Who Has Been Resuscitated From Sudden Cardiac Death
Circulation, June 11, 2002; 105(23): 2704 - 2707.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh
Antiarrhythmic Drugs in Cardiac Arrest Resuscitation: Intravenous Amiodarone or Intravenous Lidocaine?
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 61 - 64.
[PDF]


Home page
NEJMHome page
P. Dorian, D. Cass, B. Schwartz, R. Cooper, R. Gelaznikas, and A. Barr
Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation
N. Engl. J. Med., March 21, 2002; 346(12): 884 - 890.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Kulakowski, S. Karczmarewicz, G. Karpinski, M. Soszynska, and L. CeremuzYnski
Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction
Europace, January 1, 2000; 2(3): 207 - 215.
[Abstract] [PDF]


Home page
EuropaceHome page
M. Greene, D. Newman, M. Geist, M. Paquette, D. Heng, and P. Dorian
Is electrical storm in ICD patients the sign of a dying heart?: Outcome of patients with clusters of ventricular tachyarrhythmias
Europace, January 1, 2000; 2(3): 263 - 269.
[Abstract] [PDF]


Home page
CirculationHome page
S. J. Connolly
Evidence-Based Analysis of Amiodarone Efficacy and Safety
Circulation, November 9, 1999; 100(19): 2025 - 2034.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Guarnieri, S. Nolan, S. O. Gottlieb, A. Dudek, and D. R. Lowry
Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. A. Reiffel
Intravenous Amiodarone in the Management of Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 199 - 204.
[Abstract] [PDF]


Home page
Journal Watch CardiologyHome page
Amiodarone for V Tach
Journal Watch Cardiology, March 1, 1996; 1996(301): 11 - 11.
[Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement